Online Program

Return to main conference page

Thursday, January 11
Thu, Jan 11, 9:00 AM - 10:45 AM
Crystal Ballroom E
Data Integration

Algorithms for identifying disease progression dates from administrative data: the case of prostate cancer (304275)

Lusine Abrahamyan, Institute of Health Policy, Management and Evaluation, University of Toronto 
Karen Bremner, University Health Network 
Steven Carcone, Toronto Health Economics and Technology Assessment Collaborative 
Murray Krahn, Toronto Health Economics and Technology Assessment Collaborative 
Lisa Masucci, Institute of Health Policy, Management and Evaluation, University of Toronto 
*Nicholas Mitsakakis, Institute of Health Policy, Management and Evaluation, University of Toronto 
Petros Pechlivanoglou, The Hospital for Sick Children 
Valeria Rac, Institute of Health Policy, Management and Evaluation, University of Toronto 
Welson Ryan, Toronto Health Economics and Technology Assessment Collaborative 

Keywords: administrative data, state transition models, prediction, prostate cancer, criterion function

Health administrative data are a rich source of population-based information, useful for building state transition models for medical decision making. These models require estimation of transition probabilities and identification of the times that patients move through health states. Indirect prediction methods are needed to infer this information, as it is rarely available in administrative data. Various algorithms have been validated for identifying patients in a specific disease state but not the dates they entered it. Here, we consider a set of algorithms to identify the dates when prostate cancer patients become metastatic, utilizing dates, in administrative data, of: a) ICD9/10 codes for secondary malignancy, b) palliative radiation therapy, c) chemotherapy, d) ICD9/10 codes for bone disorders or procedures. We evaluate the methods using medical charts of 200 patients containing the true date of evidence of metastasis, linked to administrative data at the Institute of Clinical Evaluative Sciences in Ontario, Canada. For the evaluation, we consider criteria using both misclassification and difference between true and predicted dates for the true positives.